M. G. Garcia-Ruiz Esparza

Allogeneic peripheral blood stem cell transplantation using reduced intensity versus myeloablative conditioning regimens for the treatment of leukemia.

G. Galindo-Rodríguez, J. Vela-Ojeda, A. Rosas-Cabral, 2004, Stem cells and development.

FLT3-ITD and CD135 Over-Expression are Frequent Findings of Poor Survival in Adult Patients With Acute Leukemias.

A. Majluf-Cruz, J. Vela-Ojeda, M. G. Garcia-Ruiz Esparza, 2020, Archives of Medical Research.

Multiple myeloma-associated amyloidosis is an independent high-risk prognostic factor

A. Majluf-Cruz, H. Mayani, J. Vela-Ojeda, 2008, Annals of Hematology.

Peripheral blood mobilization of different lymphocyte and dendritic cell subsets with the use of intermediate doses of G-CSF in patients with non-Hodgkin’s lymphoma and multiple myeloma

H. Mayani, J. Vela-Ojeda, M. Moreno-Lafont, 2006, Annals of Hematology.

[CD200 protein, bad prognostic in patients with multiple myeloma].

J. Vela-Ojeda, M. G. Garcia-Ruiz Esparza, L. Montiel-Cervantes, 2015, Revista medica del Instituto Mexicano del Seguro Social.

Prognostic Value of CD95, Active Caspase-3, and Bcl-2 Expression in Adult Patients with De Novo Acute Lymphoblastic Leukemia.

J. Vela-Ojeda, M. G. Garcia-Ruiz Esparza, L. Montiel-Cervantes, 2018, Archives of medical research.

Clinical relevance of NK, NKT, and dendritic cell dose in patients receiving G-CSF-mobilized peripheral blood allogeneic stem cell transplantation

H. Mayani, J. Vela-Ojeda, M. Moreno-Lafont, 2006, Annals of Hematology.

Intermediate doses of melphalan and dexamethasone are better than vincristine, adriamycin, and dexamethasone (VAD) and polychemotherapy for the treatment of primary plasma cell leukemia

J. Vela-Ojeda, A. Rosas-Cabral, M. G. Garcia-Ruiz Esparza, 2002, Annals of Hematology.

Important decrease in invariant natural killer T, CD4+ regulatory T cells, CD8+ regulatory T cells, gamma-delta T cells, and CD4+ T lymphocytes in HIV-negative patients with hemophilia.

A. Majluf-Cruz, J. Vela-Ojeda, M. G. Garcia-Ruiz Esparza, 2020, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

Clinical relevance of NKT cells and soluble MIC-A in Hodgkin lymphoma

A. Majluf-Cruz, J. Vela-Ojeda, M. G. Garcia-Ruiz Esparza, 2020, Leukemia & lymphoma.

Donor lymphocyte infusions for relapse of chronic myeloid leukemia after allogeneic stem cell transplantation: prognostic significance of the dose of CD3+ and CD4+ lymphocytes

J. A. Aviña-Zubieta, G. Galindo-Rodríguez, J. Vela-Ojeda, 2004, Annals of Hematology.